Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438).

MLA

Thompson, John A., et al. “Total Body Irradiation, Etoposide, Cyclophosphamide, and Autologous Peripheral Blood Stem-Cell Transplantation Followed by Randomization to Therapy with Interleukin-2 versus Observation for Patients with Non-Hodgkin Lymphoma: Results of a Phase 3 Randomized Trial by the Southwest Oncology Group (SWOG 9438).” Blood, vol. 111, no. 8, Apr. 2008, pp. 4048–54. EBSCOhost, https://doi.org/10.1182/blood-2007-09-111708.

APA

Thompson, J. A., Fisher, R. I., Leblanc, M., Forman, S. J., Press, O. W., Unger, J. M., Nademanee, A. P., Stiff, P. J., Petersdorf, S. H., & Fefer, A. (2008). Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438). Blood, 111(8), 4048–4054. https://doi.org/10.1182/blood-2007-09-111708

Chicago

Thompson, John A, Richard I Fisher, Michael Leblanc, Stephen J Forman, Oliver W Press, Joseph M Unger, Auayporn P Nademanee, Patrick J Stiff, Stephen H Petersdorf, and Alexander Fefer. 2008. “Total Body Irradiation, Etoposide, Cyclophosphamide, and Autologous Peripheral Blood Stem-Cell Transplantation Followed by Randomization to Therapy with Interleukin-2 versus Observation for Patients with Non-Hodgkin Lymphoma: Results of a Phase 3 Randomized Trial by the Southwest Oncology Group (SWOG 9438).” Blood 111 (8): 4048–54. doi:10.1182/blood-2007-09-111708.